Cycle length 8 weeks Where it comes from Community research planning How to label it Anecdotal Cycle length 12 weeks Where it comes from Published trial duration and community planning How to label it Published and community context Cycle length 16 weeks Where it comes from Community research planning How to label it Anecdotal Cycle length 24 weeks Where it comes from Published trial duration How to label it Published research Read the full AOD-9604 cycle-length guide for a closer look at 8-, 12-, 16-, and 24-week timelines
Because of this targeted structure, it is discussed in research in the context of fat metabolism rather than the broader effects of full growth hormone
Extended treatment continued to limit body weight gain and white adipose tissue mass, lowered total plasma cholesterol, and showed measurable accumulation in adipose tissue consistent with the compounds lipophilic profile
The enhanced fat oxidation capacity develops before significant weight loss becomes visible
Mitochondrial & Energy Support NAD precursors (NR/NMN) Complements NAD preservation (no internal link in map)
Timing Optional Monitoring guidance is pathway-based because compound-specific clinical monitoring standards for AOD-9604 are not established